Petition · past parliament · Department of Health and Social Care
Fund access to Kaftrio for CF patients in England in line with other UK nations
Closed
3,199 signatures
What the petition asks
In Scotland, Wales and Northern Ireland the NHS is providing Kaftrio in line with US FDA regulations, in which anyone with one F508 gene and any other second gene can have Kaftrio, which has been proven to slow the decline of lung function, the primary cause of death for people with CF.
However, in England, still only patients with one F508 and certain other genes can access Kaftrio, leaving some patients deprived of living a life unlimited. The Government should work with NHS England (like they did with Orkambi) and/or provide specific extra funding to make this lifesaving drug available for people with Cystic Fibrosis with one F508 mutation, regardless of their second mutation.
Timeline
| 3 Feb 2021 | Petition opened for signatures |
| 3 Aug 2021 | Closed to new signatures |
Key facts
Signatures
3,199
Status
Closed
Department
Department of Health and Social Care
Opened
3 Feb 2021
Closed
3 Aug 2021
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 15 Jul 2026.